Почетна › Акутна миелоидна леукемија › Њујорк › Queens
Клинички испитувања за Акутна миелоидна леукемија во Queens, NY
Една студија за Акутна миелоидна леукемија бара учесници на локација во или блиску до Queens. Отворете ја за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Се регрутираФаза 2
- Northwell Health/Center for Advanced Medicine, Lake Success · на 9 милји
- Memorial Sloan Kettering Nassau, Uniondale · на 13 милји
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
- Queens Hospital Center, Jamaica · на 2 милји
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Се регрутираФаза 1
- Memorial Sloan Kettering Nassau, Uniondale · на 13 милји
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Се регрутираФаза 2
- Memorial Sloan Kettering Nassau, Uniondale · на 13 милји
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Се регрутираФаза 2
- Memorial Sloan Kettering Nassau, Uniondale · на 13 милји
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Се регрутираФаза 2
- Northwell Health/Center for Advanced Medicine, Lake Success · на 9 милји
- Memorial Sloan Kettering Nassau, Uniondale · на 13 милји
A Study of CRD3874-SI in People With Leukemia
Се регрутираФаза 1
- Memorial Sloan Kettering Nassau (All Protocol Activities), Rockville Centre · на 10 милји
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Се регрутираФаза 2
- Northwell Health/Center for Advanced Medicine, Lake Success · на 9 милји
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Се регрутираФаза 3
- The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park · на 9 милји
- NYU Langone Hospital - Long Island, Mineola · на 11 милји
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
Се регрутираФаза 2
- Clinical Research Allicance, Westbury · на 14 милји
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Се регрутираФаза 1/2
- The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park · на 9 милји
- NYU Langone Hospital - Long Island, Mineola · на 11 милји
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Се регрутираФаза 3
- Cohen Children's Medical Center, Queens
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Се регрутираФаза 1
- Northwell Health, LLC PRIME, Lake Success · на 9 милји
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
Се регрутираФаза 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre · на 10 милји
A Study of Revumenib and Mezigdomide in People With Leukemia
Се регрутираФаза 1/2
- Memorial Sloan Kettering Nassau (All Protocol Activities), Rockville Centre · на 10 милји
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
Се регрутираФаза 1
- Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre · на 10 милји
A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)
Се регрутираФаза 1
- Memorial Sloan Kettering Nassau, Uniondale · на 13 милји
A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia
Се регрутираФаза 1
- Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre · на 10 милји
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Се регрутираФаза 2/3
- New York University Langone Hospital - Long Island, Mineola · на 11 милји
A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia
Се регрутираФаза 1
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · на 13 милји
A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)
Се регрутираФаза 2
- Memorial Sloan Kettering Nassau (All Protocol Activities), Rockville Centre · на 10 милји
Испитувања за Акутна миелоидна леукемија во други градови
- Houston, TX85 студии
- New York City, NY51 студија
- Boston, MA44 студии
- Seattle, WA41 студија
- Baldwin Park, CA40 студии
- Columbus, OH35 студии
- Philadelphia, PA34 студии
- Durham, NC33 студии
- Atlanta, GA31 студија
- Tampa, FL29 студии
- Chicago, IL26 студии
- Portland, OR25 студии
Други студии во Queens
- Рак на дојка64 студии
- Рак на бели дробови со не-мали клетки49 студии
- Колоректален карцином31 студија
- Метастатски карцином28 студии
- Карцином на јајниците28 студии
- Рак на простата27 студии
- Рак (сите типови)26 студии
- Рак на ендометриумот25 студии
- Рак на бели дробови22 студии
- Множен миелом20 студии
- Карцином на панкреасот20 студии
- Сквамозноклеточен карцином на глава и врат20 студии
Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.